Hong Kong · Delayed Price · Currency is HKD Dawnrays Pharmaceutical (Holdings) Company Description
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics.
It also provides system specific medicines for various therapeutic areas, such as cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs.
The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,081 |
| CEO | Liwei Yu |
Contact Details
Address: CNT Tower Wan Chai Hong Kong | |
| Phone | 852 2111 9708 |
| Website | dawnrays.com |
Stock Details
| Ticker Symbol | 2348 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG2687M1006 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Liwei Yu | Chief Executive Officer |
| Kei Ling Li | Co-Founder and Executive Chairman |
| Yung Lai Hung | Co-Founder and Executive Director |
| Yi Jun Wu | Chief Financial Officer |
| Kit Ling Pang CPA | Company Secretary |